The emerging role of IMD 0354 on bone homeostasis by suppressing osteoclastogenesis and bone resorption, but without affecting bone formation
暂无分享,去创建一个
A. Qin | S. Fan | Zhi-jun Hu | Pan Tang | Wenxiang Chen | Xue-Sheng Jiang | Yongli Wang | Ziang Xie | Z. Jie | Zhi‐jun Hu
[1] E. Tsiridis,et al. Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss , 2019, Expert opinion on pharmacotherapy.
[2] Ziqing Li,et al. Regulator of G Protein Signaling Protein 12 (Rgs12) Controls Mouse Osteoblast Differentiation via Calcium Channel/Oscillation and Gαi‐ERK Signaling , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] R. Sirdeshmukh,et al. LYN, a key mediator in estrogen-dependent suppression of osteoclast differentiation, survival, and function. , 2019, Biochimica et biophysica acta. Molecular basis of disease.
[4] A. Qin,et al. Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] A. Qin,et al. SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis. , 2019, Biochimica et biophysica acta. Molecular basis of disease.
[6] Xiong Guo,et al. Cryptotanshinone inhibits RANKL‐induced osteoclastogenesis by regulating ERK and NF‐κB signaling pathways , 2018, Journal of cellular biochemistry.
[7] S. Bicciato,et al. Induction of immunosuppressive functions and NF-κB by FLIP in monocytes , 2018, Nature Communications.
[8] Jiandie D. Lin,et al. PGC-1α Controls Skeletal Stem Cell Fate and Bone-Fat Balance in Osteoporosis and Skeletal Aging by Inducing TAZ. , 2018, Cell stem cell.
[9] J. Tombran-Tink,et al. Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/GSK-3beta/beta-catenin signaling. , 2018, Biochimica et biophysica acta. Molecular basis of disease.
[10] Y. Soh,et al. Thymol inhibits RANKL-induced osteoclastogenesis in RAW264.7 and BMM cells and LPS-induced bone loss in mice. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[11] Y. Tabata,et al. Coupling of bone resorption and formation by RANKL reverse signalling , 2018, Nature.
[12] N. Ratcliffe,et al. The NF-κB Inhibitor, IMD-0354, Affects Immune Gene Expression, Bacterial Microbiota and Trypanosoma cruzi Infection in Rhodnius prolixus Midgut , 2018, Front. Physiol..
[13] Jiandie D. Lin,et al. PGC-1α Controls Skeletal Stem Cell Fate and Bone-Fat Balance in Osteoporosis and Skeletal Aging by Inducing TAZ. , 2018, Cell stem cell.
[14] B. Fabry,et al. NR4A1 Regulates Motility of Osteoclast Precursors and Serves as Target for the Modulation of Systemic Bone Turnover , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] Gabrielle E Foxa,et al. LRP1 Suppresses Bone Resorption in Mice by Inhibiting the RANKL‐Stimulated NF‐κB and p38 Pathways During Osteoclastogenesis , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] Kyung-Hyun Park-Min. Mechanisms involved in normal and pathological osteoclastogenesis , 2018, Cellular and Molecular Life Sciences.
[17] C. Quiroga,et al. A new role for HERPUD1 and ERAD activation in osteoblast differentiation and mineralization , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] R. Kayal,et al. OC‐STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up‐regulation of permissive fusogen CD9 , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] K. Cengel,et al. Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation‐induced osteoporosis , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] Jian-qiao Hong,et al. Low-intensity pulsed ultrasound inhibits RANKL-induced osteoclast formation via modulating ERK-c-Fos-NFATc1 signaling cascades. , 2018, American journal of translational research.
[21] Huilin Yang,et al. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling. , 2017, Acta biomaterialia.
[22] Qianchuan Zhao,et al. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] Eugenia G. Giannopoulou,et al. Hypoxia‐Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis , 2017, Immunity.
[24] Eugenia G. Giannopoulou,et al. MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERR&agr; , 2017, The Journal of clinical investigation.
[25] A. Zannettino,et al. EZH2 deletion in early mesenchyme compromises postnatal bone microarchitecture and structural integrity and accelerates remodeling , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] G. Mccarthy,et al. Intra-articular basic calcium phosphate and monosodium urate crystals inhibit anti-osteoclastogenic cytokine signalling. , 2016, Osteoarthritis and cartilage.
[27] A. Qin,et al. Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo , 2015, Scientific Reports.
[28] I. Kwon,et al. PIN1 Inhibition Suppresses Osteoclast Differentiation and Inflammatory Responses , 2015, Journal of dental research.
[29] A. Itai,et al. IκB kinase-β inhibitor IMD-0354 beneficially suppresses retinal vascular permeability in streptozotocin-induced diabetic mice. , 2014, Investigative ophthalmology & visual science.
[30] D. Graves,et al. Non-canonical Wnt4 prevents skeletal aging and inflammation by inhibiting NF-κB , 2014, Nature Medicine.
[31] S. Goodman,et al. Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target. , 2014, Acta biomaterialia.
[32] I. Komuro,et al. Inhibition of NF-κB activation by a novel IKK inhibitor reduces the severity of experimental autoimmune myocarditis via suppression of T-cell activation. , 2013, American journal of physiology. Heart and circulatory physiology.
[33] R. Reisfeld,et al. IMD-0354 Targets Breast Cancer Stem Cells: A Novel Approach for an Adjuvant to Chemotherapy to Prevent Multidrug Resistance in a Murine Model , 2013, PloS one.
[34] A. Itai,et al. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354. , 2013, Cardiovascular research.
[35] R. Baron,et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. , 2013, The Journal of clinical investigation.
[36] J. Kanis,et al. Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[37] Georg Schett,et al. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment , 2012, Nature Reviews Rheumatology.
[38] Y. Kadono,et al. Regulation of RANKL‐induced osteoclastogenesis by TGF‐β through molecular interaction between Smad3 and Traf6 , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] Hui Li,et al. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy‐induced bone loss by regulating RANKL‐mediated NF‐κB and MAPK signaling pathways , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[40] Ralph Müller,et al. Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[41] K. Guan,et al. Inhibition of osteoblastic bone formation by nuclear factor-κB , 2009, Nature Medicine.
[42] M. Mack,et al. Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosis , 2009, Nature Medicine.
[43] A. Raucci,et al. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways , 2008, Journal of cellular physiology.
[44] S. Migliaccio,et al. The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis , 2007, Clinical interventions in aging.
[45] L. Raisz. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. , 2005, The Journal of clinical investigation.
[46] T. Nakaki,et al. NF-κB as a Therapeutic Target for Cardiovascular Disease , 2002, Heart Drug.
[47] Hiroshi Takayanagi,et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. , 2002, Developmental cell.
[48] P. Chambon,et al. Aberrant Growth Plate Development in VDR/RXRγ Double Null Mutant Mice. , 2001, Endocrinology.
[49] P. Chambon,et al. Aberrant growth plate development in VDR/RXR gamma double null mutant mice. , 2001, Endocrinology.